APHB AmpliPhi Biosciences Corporatio

-0.0449  -6%
Previous Close 0.81
Open 0.80
Price To book 0.20
Market Cap 5.04M
Shares 6,627,000
Volume 423,468
Short Ratio 4.81
Av. Daily Volume 663,497

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 17844253
  2. 8-K - Current report 17844188
  3. 8-K/A [Amend] - Current report 17831516
  4. 8-K - Current report 17823576
  5. 424B4 - Prospectus [Rule 424(b)(4)] 17823509

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 to be initiated 2H 2017.
Chronic rhinosinusitis (CRS)

Latest News

  1. AmpliPhi Biosciences Corp. :APHB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
  2. APHB: Changing Focus to Developing Personalized Phage Therapies…
  3. AmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights
  4. AmpliPhi Biosciences to Hold Business Update Conference Call on May 15
  5. AmpliPhi Biosciences Announces Closing of Public Offering
  6. AmpliPhi Biosciences Crumbles After Announcing Secondary Offering
  7. AmpliPhi Biosciences Announces Pricing of $10.4 Million Underwritten Public Offering of Common Stock and Common Warrants
  8. AmpliPhi Biosciences Announces a New Strategic Emphasis on Personalized Therapies for Serious or Life-Threatening Antibiotic-Resistant Infections
  9. APHB: Looking to Follow-up on a Successful 2016
  10. AmpliPhi Biosciences Announces Presentation of Personalized Bacteriophage Therapy Case Study for Life-Threatening Antibiotic-Resistant Infection at Scientific Conference
  11. AmpliPhi Biosciences Review of Recent FDA Feedback and Drug Pipeline
  12. AmpliPhi Biosciences Announces Positive Feedback from FDA on Phase 2 Development Proposal
  13. AmpliPhi Biosciences Announces Planned One-for-Ten Reverse Stock Split
  14. AmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences
  15. AmpliPhi Biosciences Corp. :APHB-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017
  16. AmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights
  17. AmpliPhi Biosciences to Present at the 29th Annual ROTH Investor Conference
  18. AmpliPhi Biosciences Establishes Scientific Advisory Board and Appoints Dr. Timothy Lu of MIT and Broad Institute as SAB Chairman
  19. AmpliPhi Biosciences to Present at the 19th Annual BIO CEO and Investor Conference
  20. AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer